Eteplirsen approved for Duchenne muscular dystrophy

被引：6
|
作者：
Traynor, Kate
机构：
来源：
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY | 2016年 / 73卷 / 21期
关键词：
D O I：
10.2146/news160063
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：1719 / 1719
页数：1
相关论文
共 50 条
  • [1] Eteplirsen Approved for Duchenne Muscular Dystrophy: The FDA Faces a Difficult Choice
    Stein, Cy A.
    [J]. MOLECULAR THERAPY, 2016, 24 (11) : 1884 - 1885
  • [2] Eteplirsen in the treatment of Duchenne muscular dystrophy
    Lim, Kenji Rowel Q.
    Maruyama, Rika
    Yokota, Toshifumi
    [J]. DRUG DESIGN DEVELOPMENT AND THERAPY, 2017, 11 : 533 - 545
  • [3] Eteplirsen for the Treatment of Duchenne Muscular Dystrophy
    Mendell, Jerry R.
    Rodino-Klapac, Louise R.
    Sahenk, Zarife
    Roush, Kandice
    Bird, Loren
    Lowes, Linda P.
    Alfano, Lindsay
    Gomez, Ann Maria
    Lewis, Sarah
    Kota, Janaiah
    Malik, Vinod
    Shontz, Kim
    Walker, Christopher M.
    Flanigan, Kevin M.
    Corridore, Marco
    Kean, John R.
    Allen, Hugh D.
    Shilling, Chris
    Melia, Kathleen R.
    Sazani, Peter
    Saoud, Jay B.
    Kaye, Edward M.
    [J]. ANNALS OF NEUROLOGY, 2013, 74 (05) : 637 - 647
  • [4] Regarding "Eteplirsen for the treatment of Duchenne muscular dystrophy"
    Unger, Ellis F.
    Califf, Robert M.
    [J]. ANNALS OF NEUROLOGY, 2017, 81 (01) : 162 - 164
  • [5] Eteplirsen for the Treatment of Duchenne Muscular Dystrophy (DMD)
    Charleston, J. S.
    Schnell, F. J.
    Dworzak, J.
    Donoghue, C.
    Lynch, J.
    Lewis, S.
    Chen, L.
    Rodino-Klapac, L. R.
    Sahenk, Z.
    Voss, J.
    DeAlwis, U.
    Frank, D. E.
    Eliopoulos, H.
    Mendell, J. R.
    [J]. NEUROLOGY, 2017, 88
  • [6] Eteplirsen (Exondys 51) for Duchenne Muscular Dystrophy
    不详
    [J]. MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2016, 58 (1507): : 145 - 146
  • [7] Regarding "Eteplirsen for the Treatment of Duchenne Muscular Dystrophy" Reply
    Mendell, Jerry R.
    [J]. ANNALS OF NEUROLOGY, 2017, 81 (01) : 164 - 165
  • [8] Dollars and antisense for Duchenne muscular dystrophy Eteplirsen and dystrophin
    Zingariello, Carla D.
    Kang, Peter B.
    [J]. NEUROLOGY, 2018, 90 (24) : 1091 - 1092
  • [9] FDA Approves Eteplirsen for Duchenne Muscular Dystrophy: The Next Chapter in the Eteplirsen Saga
    Aartsma-Rus, Annemieke
    Krieg, Arthur M.
    [J]. NUCLEIC ACID THERAPEUTICS, 2017, 27 (01) : 1 - +
  • [10] Deflazacort approved for Duchenne muscular dystrophy
    Traynor, Kate
    [J]. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2017, 74 (06) : 368 - 368
12345